These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26048988)

  • 21. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor.
    Lee FJ; Pei L; Moszczynska A; Vukusic B; Fletcher PJ; Liu F
    EMBO J; 2007 Apr; 26(8):2127-36. PubMed ID: 17380124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
    Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
    Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.
    Eriksen J; Jørgensen TN; Gether U
    J Neurochem; 2010 Apr; 113(1):27-41. PubMed ID: 20085610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol modulation of interactions between psychostimulants and dopamine transporters.
    Chen R
    Adv Pharmacol; 2024; 99():35-59. PubMed ID: 38467486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats.
    Yu PL; Wu CI; Lee TS; Pan WH; Wang PS; Wang SW
    J Cell Biochem; 2009 Dec; 108(6):1318-24. PubMed ID: 19830701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analyses of alpha-synuclein expression levels in rat brain tissues and transfected cells.
    Wersinger C; Banta M; Sidhu A
    Neurosci Lett; 2004 Mar; 358(2):95-8. PubMed ID: 15026157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Lasting Epigenetic Changes in the Dopamine Transporter in Adult Animals Exposed to Amphetamine during Embryogenesis: Investigating Behavioral Effects.
    Ke T; Ambigapathy G; Ton T; Dhasarathy A; Carvelli L
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter.
    Nawaratne V; McLaughlin SP; Mayer FP; Gichi Z; Mastriano A; Carvelli L
    Front Cell Neurosci; 2021; 15():681539. PubMed ID: 34512264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the structure and function of the dopamine transporter and its protein interactions.
    Nepal B; Das S; Reith ME; Kortagere S
    Front Physiol; 2023; 14():1150355. PubMed ID: 36935752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter membrane mobility is bidirectionally regulated by phosphorylation and palmitoylation.
    Shetty M; Bolland DE; Morrell J; Grove BD; Foster JD; Vaughan RA
    Curr Res Physiol; 2023; 6():100106. PubMed ID: 38107792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic control of the dopamine transporter in neurotransmission and homeostasis.
    Bu M; Farrer MJ; Khoshbouei H
    NPJ Parkinsons Dis; 2021 Mar; 7(1):22. PubMed ID: 33674612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine transporter trafficking: rapid response on demand.
    Chen R; Furman CA; Gnegy ME
    Future Neurol; 2010 Jan; 5(1):123. PubMed ID: 20174452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Genomic Analysis of Amphetamine Sensitivity in
    Karam CS; Williams BL; Morozova I; Yuan Q; Panarsky R; Zhang Y; Hodgkinson CA; Goldman D; Kalachikov S; Javitch JA
    Front Psychiatry; 2022; 13():831597. PubMed ID: 35250674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.
    Buttarelli FR; Fanciulli A; Pellicano C; Pontieri FE
    Curr Neuropharmacol; 2011 Jun; 9(2):278-88. PubMed ID: 22131937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine transporter activity is modulated by α-synuclein.
    Butler B; Goodwin S; Saha K; Becker J; Sambo D; Davari P; Khoshbouei H
    J Biol Chem; 2015 Jul; 290(31):19009. PubMed ID: 26232401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comment on: Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center.
    Bhattacharjee S; Shankar V; Elkider M
    Mov Disord Clin Pract; 2017; 4(1):154. PubMed ID: 30713965
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction: α-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity.
    Chen RHC; Wislet-Gendebien S; Samuel F; Visanji NP; Zhang G; Marsilio D; Langman T; Fraser PE; Tandon A
    J Biol Chem; 2020 Oct; 295(41):14248. PubMed ID: 33037082
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.
    Dehay B; Bourdenx M; Gorry P; Przedborski S; Vila M; Hunot S; Singleton A; Olanow CW; Merchant KM; Bezard E; Petsko GA; Meissner WG
    Lancet Neurol; 2015 Aug; 14(8):855-866. PubMed ID: 26050140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.